UFP Technologies CFO sells over $787k in company stock By Investing.com

UFP Technologies Inc. (NASDAQ:UFPT), a company specializing in surgical and medical instruments and apparatus, has reported a significant stock transaction by Chief Financial Officer Ronald J. Lataille. According to the latest filing, Lataille sold a total of 2,392 shares of the company’s common stock, resulting in proceeds exceeding $787,000.

The transactions, which took place on August 23, 2024, involved shares sold at weighted average prices that varied within specific ranges. The first batch of 1,307 shares was sold at prices ranging from $328.02 to $328.80, while the second batch of 783 shares ranged from $329.00 to $329.85. The third and fourth batches included 177 and 125 shares sold at price ranges of $330.02 to $330.94, and $331.32 to $331.76 respectively.

Following these sales, Lataille’s indirect ownership in the company, held in trust, has been adjusted to reflect the new total of shares owned. It is also noted that Lataille directly holds an additional 8,673 shares of UFP Technologies Inc.

The transactions were conducted in a series of multiple trades, and the filing indicates that Lataille is willing to provide full information regarding the number of shares sold at each separate price within the reported ranges upon request.

Investors and followers of UFP Technologies Inc. often monitor insider transactions like these as they provide insights into the executives’ perspectives on the company’s value and future performance. The stock market typically views insider sales and purchases with interest as they can indicate the leadership’s confidence in the company’s prospects.

For those interested in the detailed transaction prices and quantities, the information is available upon request from the company or as outlined in the footnotes of the SEC filing.

In other recent news, UFP Technologies has been active in strategic acquisitions, aiming to enhance its offerings in the medical technology sector. The company has acquired AQF Medical, a specialist in solutions for medical devices, for approximately $48 million. This acquisition marks UFP’s fourth in a series of recent strategic moves, including the purchases of ARJ Enterprises, Welch Fluorocarbon, and Marble Medical.

The company’s expansion strategy has been met with positive responses from analysts. Lake Street Capital Markets has maintained a Buy rating on UFP Technologies and raised the price target to $392, projecting a strong second-quarter earnings report and a GAAP EPS of $9 in 2026, potentially surpassing $10 in 2027. However, KeyBanc has reiterated a Sector Weight rating on UFP Technologies, citing valuation reasons.

These recent developments reflect UFP Technologies’ commitment to its growth strategy and financial targets, which include a revenue growth rate of 12%-18%, a gross margin range of 28%-31%, and an operating margin between 15%-18%. The company’s recent acquisitions are expected to contribute positively to its financial performance and enhance its product offerings in the medical technology sector.

InvestingPro Insights

UFP Technologies Inc. (NASDAQ:UFPT) has been a standout performer in the market, reflected in its significant stock price appreciation. An InvestingPro Tip highlights that the company has seen a “High return over the last year,” with data showing a 98.14% one-year price total return as of the latest available figures. This aligns with the CFO’s recent stock sales, as executives often transact based on their assessment of the company’s valuation and future prospects.

Another InvestingPro Tip indicates that “Cash flows can sufficiently cover interest payments,” which speaks to the company’s financial health and its ability to service debt. This is an important consideration for investors gauging the sustainability of a company’s growth and profitability.

From the InvestingPro Data, the company’s robust financials are evident, with a Gross Profit Margin of 28.02% for the last twelve months as of Q2 2024. Additionally, the company’s Price to Book ratio stands at 8.32, suggesting a premium valuation that investors are willing to pay for its net assets. The Price/Earnings (P/E) ratio, at 51.89, also supports the notion that the market has high expectations for UFPT’s earnings growth potential.

For those looking to delve deeper into UFP Technologies Inc.’s financial metrics and insider transactions, InvestingPro offers a comprehensive suite of additional tips—15 in total for UFPT—which can provide further insights into the company’s performance and future outlook. To explore these insights, visit: https://www.investing.com/pro/UFPT

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.